Compulsory Licensing and Access to Medicine in Developing Countries
نویسنده
چکیده
منابع مشابه
An exploration of compulsory licensing as an effective policy tool for antiretroviral drugs in India.
Access to affordable drugs for the treatment of HIV/AIDS and other diseases is increasingly challenging in many developing countries such as Brazil, South Africa, and India. These challenges are in part the result of strengthened patent laws mandated by the 1994 Trade-Related Aspects of Intellectual Property Rights (TRIPS) treaty. However, there are underutilized instruments within TRIPS that g...
متن کاملData exclusivity exceptions and compulsory licensing to promote generic medicines in the European Union: A proposal for greater coherence in European pharmaceutical legislation
The challenge of providing access to high-priced patented medicines is a global problem affecting all countries. A decade and a half ago the use of flexibilities contained in the World Trade Organization Agreement on Trade Related Aspects of Intellectual Property Rights, in particular compulsory licensing, was seen as a mechanism to respond to high-price medicines for the treatment of HIV/AIDS ...
متن کاملCompulsory licensing of generic drugs remains mired in quagmires.
The goal was straightforward and highly-laudable: find ways of providing access to cheaper, generic versions of patented drugs in developing countries to combat public health crises resulting from HIV/AIDS, tuberculosis, malaria or other epidemics. Yet, nearly a decade after global agencies began to pave the way for developing countries to buy or manufacture patented medicines at low prices to ...
متن کاملSustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and Thailand.
UNLABELLED ANTIRETROVIRAL ROLLOUT IN BRAZIL AND THAILAND: Brazil and Thailand are among few developing countries to achieve universal access to antiretroviral therapy. Three factors were critical to this success: legislation for free access to treatment; public sector capacity to manufacture medicines; and strong civil society action to support government initiatives to improve access. LOCAL PR...
متن کاملComment on Ford et al., 'Sustaining access to antiretroviral therapy in developing countries: lessons from Brazil and Thailand'.
Efforts to ensure access to expensive, patented drugs Developing countries were not required to grant patents on medicines until 2005, but under US government threats of trade sanctions, Thailand and Brazil began doing so at least ten years prior to this date. Brazil has used price negotiations with multi-national pharmaceutical companies to lower the price of newer patented antiretrovirals. Ho...
متن کامل